Novel lipid-modifying therapies addressing unmet needs in cardiovascular disease

Cardiovascular disease (CVD) remains a major cause of morbidity and mortality worldwide. Currently, it is well established that dyslipidemia is one of the major risk factors leading to the development of atherosclerosis and CVD. Statins remain the standard-of-care in the treatment of hypercholestero...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmas, Constantine E, Sourlas, Andreas, Silverio, Delia, Montan, Peter D, Guzman, Eliscer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885448/
https://www.ncbi.nlm.nih.gov/pubmed/31798792
http://dx.doi.org/10.4330/wjc.v11.i11.256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885448/
https://www.ncbi.nlm.nih.gov/pubmed/31798792
http://dx.doi.org/10.4330/wjc.v11.i11.256

Ejemplares similares